Curaleaf Holdings (CURLF) Cash from Investing Activities (2019 - 2024)

Curaleaf Holdings (CURLF) recorded quarterly Cash from Investing Activities of -$26.0 million in Q4 2024, up 6.25% quarter-over-quarter from -$27.7 million in Q3 2024, and down 26.31% on a YoY basis from -$35.3 million in Q1 2024.

Curaleaf Holdings (CURLF) Cash from Investing Activities (2019 - 2024) Analysis & Trends

Curaleaf Holdings' Cash from Investing Activities history runs 6 years deep, the most recent figure standing at -$26.0 million for Q4 2024.

  • In Q4 2024, Cash from Investing Activities fell 26.31% year-over-year to -$26.0 million; the TTM figure through Dec 2024 stood at -$93.8 million (down 19.24% YoY), while the FY2025 annual figure was -$69.2 million, up 26.25% from the prior year.
  • Cash from Investing Activities was -$26.0 million for Q4 2024 at Curaleaf Holdings, up from -$27.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $26.7 billion in Q2 2023 to a low of -$26.7 billion in Q1 2023.
  • Historically, Cash from Investing Activities has averaged -$31.1 million across 5 years, with a median of -$29.6 million in 2021.
  • Biggest YoY gain for Cash from Investing Activities was 97.08% in 2021; the steepest drop was 88207.28% in 2021.
  • A 5-year view of Cash from Investing Activities shows it stood at -$26.7 million in 2020, then slumped by 211.2% to -$83.1 million in 2021, then surged by 54.1% to -$38.1 million in 2022, then soared by 46.06% to -$20.6 million in 2023, then retreated by 26.31% to -$26.0 million in 2024.
  • The last three Cash from Investing Activities figures came in at -$26.0 million (Q4 2024), -$27.7 million (Q3 2024), and $17.5 billion (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -2.08 Bn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 25.99 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -15.45 Mn
10 Curaleaf Holdings - - 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -25.99 Mn
Dec 31, 2024 -25.99 Mn
Sep 30, 2024 -27.72 Mn
Sep 30, 2024 -27.72 Mn
Jun 30, 2024 17.51 Bn
Jun 30, 2024 17.51 Bn
Mar 31, 2024 -17.55 Bn
Mar 31, 2024 -17.55 Bn
Dec 31, 2023 -20.58 Mn
Dec 31, 2023 -20.58 Mn
Sep 30, 2023 -20.17 Mn
Sep 30, 2023 -20.17 Mn
Jun 30, 2023 26.69 Bn
Jun 30, 2023 26.69 Bn
Mar 31, 2023 -26.73 Bn
Mar 31, 2023 -26.73 Bn
Dec 31, 2022 -38.15 Mn
Dec 31, 2022 -38.15 Mn
Sep 30, 2022 -42.11 Mn
Sep 30, 2022 -42.11 Mn